Curreen Capital Partners reported a strong performance in the third quarter of 2025, achieving a notable 9% increase in fund value. This growth was bolstered by...
Medicare beneficiaries face a reduction in prescription drug coverage options this fall, continuing a trend that has persisted for several years. As the open enrollment period...
